| 000 | 01569 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514164538.0 | ||
| 264 | 0 | _c20040220 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.48.1.80-85.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzoulay-Dupuis, E | |
| 245 | 0 | 0 |
_aEfficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJan 2004 |
||
| 300 |
_a80-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAmidohydrolases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAmoxicillin _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoroquinolones _xpharmacology |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacokinetics |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 |
_aMacrolides _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPenicillins _xpharmacology |
| 650 | 0 | 4 |
_aPneumonia, Pneumococcal _xdrug therapy |
| 650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aMohler, J | |
| 700 | 1 | _aBédos, J P | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 1 _gp. 80-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.1.80-85.2004 _zAvailable from publisher's website |
| 999 |
_c14424395 _d14424395 |
||